Everybody Patient Sheets Hero Small

General Practice

Gordon Royle pradaxa
+Clinical

New Zealand contributes to trial success for dabigatran reversal

New Zealanders made up about a third of participants when idarucizumab was trialled internationally for reversing anti-coagulation

Read more
By Virginia McMillan
Friday 18 August 2017, 05:21 PM
Back to The newspaper

Article archive

Latest news

PM expects more COVID cases in expanding Auckland outbreak

13/08/2020

Better prepared this time, but second lockdown will have mental health impact

13/08/2020

Strike action by southern lab workers lifted, nurse ballot results still unknown

13/08/2020

Primary care leaders seek government assurance on COVID-19 funding

13/08/2020

Popcorn Panel: DHBs commit to sustainable funding model for pharmacy - guild

13/08/2020

GP leaders call for primary care expert to be included in Simpson report implementation

13/08/2020

Q&A: ProCare clinical director Allan Moffitt discusses implications of Alert Level 3 for Auckland practices

12/08/2020

Heed the lockdown and beware misinformation

12/08/2020

Latest issue

NZD Cover 12082020

12 August 2020

View all issues

Facebook

New Zealand Doctor

Twitter